{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:03:58Z","timestamp":1768262638301,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Meyer Foundation, \u201cA. Meyer\u201d University Children's Hospital (PB)"},{"name":"Foundation of the Cassa di Risparmio of Florence (LF)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.exer.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T14:16:26Z","timestamp":1364048186000},"page":"27-35","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice"],"prefix":"10.1016","volume":"111","author":[{"given":"Massimo","family":"Dal Monte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Casini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"la Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Isacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2013.03.013_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/labinvest.3700277","article-title":"Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization","volume":"85","author":"Chan","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2013.03.013_bib2","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1167\/iovs.12-9691","article-title":"Propranolol inhibition of \u03b2-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib3","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1167\/iovs.12-11199","article-title":"Author response: different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1167\/iovs.11-9408","article-title":"Beta-adrenoreceptor (\u03b2-AR) agonism influences retinal responses to hypoxia in a mouse model of retinopathy of prematurity","volume":"53","author":"Dal Monte","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1167\/iovs.09-4472","article-title":"Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy","volume":"51","author":"Dal Monte","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. A shift to the posterior segment","volume":"13","author":"del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exer.2013.03.013_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0038-1646562","article-title":"Endothelial cells and normal circulating haemopoietic cells share a number of surface antigens","volume":"61","author":"Favaloro","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.exer.2013.03.013_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2431-10-83","article-title":"Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491","volume":"10","author":"Filippi","year":"2010","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.exer.2013.03.013_bib9","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1167\/iovs.12-10721","article-title":"Different efficacy of propranolol in mice with oxygen-induced retinopathy: could differential effects of propranolol be related to differences in mouse strains?","volume":"53","author":"Filippi","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib8","doi-asserted-by":"crossref","DOI":"10.3109\/14767058.2012.755169","article-title":"Propranolol concentrations after oral administration in term and preterm neonates","author":"Filippi","year":"2013","journal-title":"J.\u00a0Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.exer.2013.03.013_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.exer.2013.03.013_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archopht.130.1.117","article-title":"\u03b2-Blocking and racial variation in the severity of retinopathy of prematurity","volume":"130","author":"Good","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2013.03.013_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"Early treatment for retinopathy of prematurity cooperative group. The incidence and course of retinopathy of prematurity: findings from\u00a0the early treatment for retinopathy of prematurity study","volume":"116","author":"Good","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2013.03.013_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jop.2011.0055","article-title":"Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration","volume":"27","author":"Hao","year":"2011","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2013.03.013_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2009.02.020","article-title":"Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye","volume":"136","author":"Hironaka","year":"2009","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.exer.2013.03.013_bib16","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A\u00a0randomized controlled trial of propranolol for infantile hemangiomas","volume":"128","author":"Hogeling","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2013.03.013_bib17","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.neurobiolaging.2005.10.021","article-title":"Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability","volume":"27","author":"Hughes","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exer.2013.03.013_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.exer.2010.04.014","article-title":"Application of isoproterenol inhibits diabetic-like changes in the rat retina","volume":"91","author":"Jiang","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2013.03.013_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1124\/jpet.109.161570","article-title":"Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve","volume":"332","author":"Kadam","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exer.2013.03.013_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.preteyeres.2012.04.004","article-title":"Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease","volume":"31","author":"Kur","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2013.03.013_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00417-009-1116-4","article-title":"Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2013.03.013_bib22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of infancy: risks and recommendations","volume":"26","author":"Lawley","year":"2009","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.exer.2013.03.013_bib23","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2013.03.013_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.exer.2013.03.013_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199120060-00001","article-title":"Nonlinear pharmacokinetics: clinical Implications","volume":"20","author":"Ludden","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.exer.2013.03.013_bib26","doi-asserted-by":"crossref","first-page":"d1030","DOI":"10.2741\/1056","article-title":"Animal models of oxygen-induced retinopathy","volume":"8","author":"Madan","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.exer.2013.03.013_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejpb.2011.11.006","article-title":"A\u00a0pharmacokinetic study of a combination of beta adrenoreceptor antagonists \u2013 in the isolated perfused ovine eye","volume":"80","author":"Mains","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2013.03.013_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic effects of \u03b22 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.exer.2013.03.013_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0092-8674(03)00773-6","article-title":"Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control","volume":"115","author":"Mazumder","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.exer.2013.03.013_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjcard.2012.05.029","article-title":"Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors","volume":"110","author":"McLean","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.exer.2013.03.013_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2012.03.010","article-title":"Intercapillary bridging cells: immunocytochemical characteristics of cells that connect blood vessels in the retina","volume":"98","author":"Mendes-Jorge","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2013.03.013_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/nar\/gkg011","article-title":"RT Primer DB: the real-time PCR primer and probe database","volume":"31","author":"Pattyn","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exer.2013.03.013_bib33","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1542\/peds.2007-0803","article-title":"Infantile hemangiomas and retinopathy of prematurity: possible association","volume":"123","author":"Praveen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2013.03.013_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000027483","article-title":"Oxygen-induced retinopathy in the newborn rat: morphological and immunohistological findings in animals treated with topical timolol maleate","volume":"214","author":"Ricci","year":"2000","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2013.03.013_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2013.03.013_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1043-6618(92)90530-O","article-title":"Distribution of topically administered drugs to the posterior segment of rabbit eye","volume":"25","author":"Romanelli","year":"1992","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2013.03.013_bib37","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2013.03.013_bib38","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2013.03.013_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00431-010-1324-2","article-title":"Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas","volume":"170","author":"Schiestl","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.exer.2013.03.013_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2006.09.048","article-title":"Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells","volume":"553","author":"Seya","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2013.03.013_bib41","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib42","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.03.013_bib43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/adc.2010.208884","article-title":"Propranolol for infantile haemangiomas: a review","volume":"96","author":"Starkey","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.exer.2013.03.013_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200204000-00009","article-title":"Timolol concentrations in rat ocular tissues and plasma after topical and intraperitoneal dosing","volume":"11","author":"Tan","year":"2002","journal-title":"J.\u00a0Glaucoma"},{"key":"10.1016\/j.exer.2013.03.013_bib45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S0952523807070605","article-title":"Localization of alpha 2 receptors in ocular tissues","volume":"24","author":"Woldemussie","year":"2007","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2013.03.013_bib46","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1093\/nar\/gng154","article-title":"A\u00a0PCR primer bank for quantitative gene expression analysis","volume":"31","author":"Wang","year":"2003","journal-title":"Nucleic Acids Res."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483513000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483513000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T04:57:31Z","timestamp":1562821051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483513000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":46,"alternative-id":["S0014483513000730"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2013.03.013","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}